Identification of MicroRNAs as Potential Biomarker for Gastric Cancer by System Biological Analysis

Gastric cancers (GC) have the high morbidity and mortality rates worldwide and there is a need to identify sufficiently sensitive biomarkers for GC. MicroRNAs (miRNAs) could be promising potential biomarkers for GC diagnosis. We employed a systematic and integrative bioinformatics framework to identify GC-related microRNAs from the public microRNA and mRNA expression dataset generated by RNA-seq technology. The performance of the 17 candidate miRNAs was evaluated by hierarchal clustering, ROC analysis, and literature mining. Fourteen have been found to be associated with GC and three microRNAs (miR-211, let-7b, and miR-708) were for the first time reported to associate with GC and may be used for diagnostic biomarkers for GC.

[1]  T. Lumley,et al.  gplots: Various R Programming Tools for Plotting Data , 2015 .

[2]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.

[3]  Jae Yong Cho,et al.  AMPKα modulation in cancer progression: multilayer integrative analysis of the whole transcriptome in Asian gastric cancer. , 2012, Cancer research.

[4]  C. Mathers,et al.  Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 , 2010, International journal of cancer.

[5]  C. Creighton,et al.  Widespread deregulation of microRNA expression in human prostate cancer , 2008, Oncogene.

[6]  Fang Wang,et al.  Characterization of microRNA-29 family expression and investigation of their mechanistic roles in gastric cancer. , 2014, Carcinogenesis.

[7]  Shu-Chun Lin,et al.  miR-211 promotes the progression of head and neck carcinomas by targeting TGFβRII. , 2013, Cancer letters.

[8]  J. Scheiman,et al.  Helicobacter pylori and gastric cancer. , 1999, The American journal of medicine.

[9]  Sung-Chou Li,et al.  MicroRNA dysregulation in gastric cancer. , 2012, Current pharmaceutical design.

[10]  Stefania Bortoluzzi,et al.  Impact of microRNAs on regulatory networks and pathways in human colorectal carcinogenesis and development of metastasis , 2013, BMC Genomics.

[11]  Eva Hamade,et al.  Circulating miR-150 and miR-342 in plasma are novel potential biomarkers for acute myeloid leukemia , 2013, Journal of Translational Medicine.

[12]  P. Muti,et al.  miR-204 targets Bcl-2 expression and enhances responsiveness of gastric cancer , 2012, Cell Death and Disease.

[13]  I. Behrmann,et al.  New Target Genes of MITF-Induced microRNA-211 Contribute to Melanoma Cell Invasion , 2013, PloS one.

[14]  L. Mishra,et al.  The role of PRAJA and ELF in TGF-β signaling and gastric cancer , 2005, Cancer biology & therapy.

[15]  Jiajia Chen,et al.  Clear cell renal cell carcinoma associated microRNA expression signatures identified by an integrated bioinformatics analysis , 2013, Journal of Translational Medicine.

[16]  D. Bartel.  MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.

[17]  Jun Yu,et al.  MicroRNA dysregulation in gastric cancer: a new player enters the game , 2010, Oncogene.

[18]  Jiajia Chen,et al.  Identification of novel microRNA regulatory pathways associated with heterogeneous prostate cancer , 2013, BMC Systems Biology.

[19]  H. Ashktorab,et al.  MicroRNA-211 Expression Promotes Colorectal Cancer Cell Growth In Vitro and In Vivo by Targeting Tumor Suppressor CHD5 , 2012, PloS one.

[20]  F. Vilardell.  [Diagnosis of gastric cancer]. , 1975, Schweizerische medizinische Wochenschrift.

[21]  Bairong Shen,et al.  Identification of candidate miRNA biomarkers from miRNA regulatory network with application to prostate cancer , 2014, Journal of Translational Medicine.

[22]  Brad T. Sherman,et al.  Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.

[23]  T. Sawada,et al.  Phosphorylated Smad2 in Advanced Stage Gastric Carcinoma , 2010, BMC Cancer.

[24]  C. Fenoglio-Preiser,et al.  Pathologic and phenotypic features of gastric cancer. , 1996, Seminars in oncology.

[25]  Bairong Shen,et al.  Identification of MicroRNA as Sepsis Biomarker Based on miRNAs Regulatory Network Analysis , 2014, BioMed research international.

[26]  S. Meltzer,et al.  A review of the genomics of gastric cancer. , 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[27]  本山 一夫.  Clinical significance of high mobility group A2 in human gastric cancer and its relationship to let-7 microRNA family , 2009 .

[28]  Brad T. Sherman,et al.  Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists , 2008, Nucleic acids research.

[29]  Kurt Hornik,et al.  The Comprehensive R Archive Network , 2012 .

[30]  J. Parsonnet.  Helicobacter pylori and gastric cancer. , 1993, Gastroenterology clinics of North America.

[31]  Lihua Zhang,et al.  MiR-204 down regulates SIRT1 and reverts SIRT1-induced epithelial-mesenchymal transition, anoikis resistance and invasion in gastric cancer cells , 2013, BMC Cancer.

[32]  Qingwei Wang,et al.  MicroRNA expression and its implication for the diagnosis and therapeutic strategies of gastric cancer. , 2010, Cancer letters.

[33]  Ji-Lin Wang,et al.  Candidate microRNA Biomarkers in Human Gastric Cancer: A Systematic Review and Validation Study , 2013, PloS one.

[34]  C. Croce,et al.  MicroRNA gene expression deregulation in human breast cancer. , 2005, Cancer research.

[35]  Xiaohua Li,et al.  Survival prediction of gastric cancer by a seven-microRNA signature , 2009, Gut.

[36]  Wong-Ho Chow,et al.  Principal component analysis of dietary and lifestyle patterns in relation to risk of subtypes of esophageal and gastric cancer. , 2011, Annals of epidemiology.

[37]  M. Koch,et al.  Invasion front‐specific expression and prognostic significance of microRNA in colorectal liver metastases , 2011, Cancer science.

[38]  Lin Gao,et al.  ppiPre: predicting protein-protein interactions by combining heterogeneous features , 2013, BMC Systems Biology.

[39]  Kazunori Kataoka,et al.  Improvement of cancer-targeting therapy, using nanocarriers for intractable solid tumors by inhibition of TGF-β signaling , 2007, Proceedings of the National Academy of Sciences.

[40]  Romdhane Rekaya,et al.  LSOSS: Detection of Cancer Outlier Differential Gene Expression , 2010, Biomarker insights.

[41]  Ugo Boggi,et al.  High-Throughput MicroRNA (miRNAs) Arrays Unravel the Prognostic Role of MiR-211 in Pancreatic Cancer , 2012, PloS one.

[42]  A. Jemal,et al.  Cancer Statistics, 2006 , 2006, CA: a cancer journal for clinicians.

[43]  Yongming Qiu,et al.  miR-708 acts as a tumor suppressor in human glioblastoma cells. , 2013, Oncology reports.

[44]  Michael Goggins,et al.  MicroRNA Alterations of Pancreatic Intraepithelial Neoplasias , 2011, Clinical Cancer Research.

[45]  Greg Tucker-Kellogg,et al.  A Comparison of Methods for Data-Driven Cancer Outlier Discovery, and An Application Scheme to Semisupervised Predictive Biomarker Discovery , 2011, Cancer informatics.

[46]  B. Burwinkel,et al.  Cancer diagnosis and prognosis decoded by blood-based circulating microRNA signatures , 2013, Front. Genet..

[47]  Y. Doki,et al.  Let-7 Expression Is a Significant Determinant of Response to Chemotherapy through the Regulation of IL-6/STAT3 Pathway in Esophageal Squamous Cell Carcinoma , 2012, Clinical Cancer Research.

[48]  R. Stephens,et al.  Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. , 2006, Cancer cell.